NCT04835246 Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous Lesions Status UNKNOWN Phase NA
NCT04834778 A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD) Status COMPLETED Phase PHASE1
NCT04834661 Performing Laparoscopic Surgery for Colorectal and Gastric Cancer Outside the Primary Registered Medical Institution Status COMPLETED Phase N/A
NCT04830618 Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms Status COMPLETED Phase N/A
NCT04826107 Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer Status UNKNOWN Phase PHASE2
NCT04817826 TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC. Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04808466 Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Status UNKNOWN Phase PHASE2
NCT04801459 Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y Reconstruction Status UNKNOWN Phase NA
NCT04798820 The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING) Status RECRUITING Phase NA
NCT04798781 Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT04795063 Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer Status NOT_YET_RECRUITING Phase NA
NCT04791293 The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric Cancer Status COMPLETED Phase N/A
NCT04787354 Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX) Status RECRUITING Phase PHASE3
NCT04782791 Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT04778345 Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer Status UNKNOWN Phase NA
NCT04777162 Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer Status UNKNOWN Phase PHASE2
NCT04772989 A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies Status COMPLETED Phase PHASE1